TY - JOUR T1 - Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer JO - Health Technology Assessment PY - 2010/10/01 AU - Whyte S AU - Pandor A AU - Stevenson M AU - Rees A ED - DO - DOI: 10.3310/hta14suppl2-07 PB - National Institute for Health Research VL - 14 IS - Suppl 2 SP - 47 EP - 53 Y2 - 2025/07/29 ER -